Drug Insights

Effortless Searching: How to Find Modafinil on Synapse

4 March 2024
2 min read

Modafinil, a minuscule molecular compound marketed as PROVIGIL, received its initial approval in 1992. This drug is principally utilized to enhance vigilance among adult patients who are plagued by excessive sleepiness, a symptom of narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). However, it is important to note that PROVIGIL is not intended to treat the underlying causes of these sleep disorders; rather, its function is to heighten the patient's aptitude to remain alert during daylight hours. As a central nervous system stimulant, Modafinil operates by augmenting the activity of particular chemicals located within the brain that are implicated in regulating the sleep-wake cycle. Click on the image below to begin the exploration journey of Modafinil through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

ImmPACT Bio Secures $8M CIRM Grant for Dual-Target CAR T Therapy Trial in Lupus
Latest Hotspot
3 min read
ImmPACT Bio Secures $8M CIRM Grant for Dual-Target CAR T Therapy Trial in Lupus
4 March 2024
ImmPACT Bio Receives $8M from CIRM for Early-Stage Trial of Novel Dual-Target CAR T-Cell Treatment IMPT-514, Aimed at Tough-to-Treat Lupus Kidney Disease and Widespread Lupus Conditions.
Read →
Progress in the Discovery of New Drugs Targeting GPCR Class for Gastric Cancer
Hot Spotlight
14 min read
Progress in the Discovery of New Drugs Targeting GPCR Class for Gastric Cancer
1 March 2024
Gastric Cancer (GC) is a deadly global malignancy with over 1 million new cases in 2022, resulting in 783,000 deaths.
Read →
Making the Most Out of Synapse: Searching for Paroxetine
Drug Insights
2 min read
Making the Most Out of Synapse: Searching for Paroxetine
1 March 2024
Paroxetine, a small molecule drug, is a serotonin reuptake inhibitors (SSRIs) .
Read →
Development Trends of Peptide Pharmaceuticals
Hot Spotlight
17 min read
Development Trends of Peptide Pharmaceuticals
1 March 2024
This article provides an interpretation of a review published in the 2021 issue of "Nature Reviews Drug Discovery", which analyzes the history and trends of peptide drug development over the past 100 years.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.